Guidelines for Penile Cancer

Penile Enlargement » Dr. Elist Health Blog » Guidelines for Penile Cancer

[ A+ ] /[ A- ]

Penile Cancer Guidelines

Penile cancer accounts for 0.4% to 0.6% of all malignant neoplasms in the United States and Europe.

In 2010, an estimated 1250 new cases of penile cancer were diagnosed in the United States and there were about 310 related deaths.

Response Rate

For carcinoma in situ and superficial verrucous carcinoma, the response rate at 5 years with 5-fluorouracil or imiquimod was 60% to 70% (World J Urol. 2009; 27:179-187).

In this setting, CO2 and Nd: YAG laser ablation can also be used, although retreatment rates are quite high (about 20% to 30%),

By | 2017-11-13T15:29:08+00:00 April 15th, 2013|Categories: Male Sexual Health, Prostate Health|Tags: , |0 Comments

About the Author:

Dr. Elist (James J. Elist, M.D.,F.A.C.S., F.I.C.S.), has been in private practice in Beverly Hills, California since 1982 specializing in Urology. Dr Elist ‘s major interests (sub specialties) include impotency, male sexual dysfunction, infertility and Male Enhancement Procedures(Penile Enlargement and Testicular Enlargement).